These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16696947)

  • 21. A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function.
    Chambers RJ; Abrams K; Castleberry TA; Cheng JB; Fisher DA; Kamath AV; Marfat A; Nettleton DO; Pillar JD; Salter ED; Sheils AL; Shirley JT; Turner CR; Umland JP; Lam KT
    Bioorg Med Chem Lett; 2006 Feb; 16(3):718-21. PubMed ID: 16263279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte.
    Kadoshima-Yamaoka K; Murakawa M; Goto M; Tanaka Y; Inoue H; Murafuji H; Hayashi Y; Nagahira K; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
    Int Immunopharmacol; 2009 Jan; 9(1):97-102. PubMed ID: 18992850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of cyclic AMP concentration in bovine endometrial stromal cells by arachidonic acid.
    Cheng Z; Sheldrick EL; Marshall E; Wathes DC; Abayasekara DR; Flint AP
    Reproduction; 2007 May; 133(5):1017-26. PubMed ID: 17616730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic adenosine 3',5'monophosphate/protein kinase A and mitogen-activated protein kinase 3/1 pathways are involved in adenylate cyclase-activating polypeptide 1-induced common alpha-glycoprotein subunit gene (Cga) expression in mouse pituitary gonadotroph LbetaT2 cells.
    Harada T; Kanasaki H; Mutiara S; Oride A; Miyazaki K
    Biol Reprod; 2007 Oct; 77(4):707-16. PubMed ID: 17596563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
    Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma.
    Sun JG; Deng YM; Wu X; Tang HF; Deng JF; Chen JQ; Yang SY; Xie QM
    Life Sci; 2006 Oct; 79(22):2077-85. PubMed ID: 16875702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reciprocal roles between caffeine and estrogen on bone via differently regulating cAMP/PKA pathway: the possible mechanism for caffeine-induced osteoporosis in women and estrogen's antagonistic effects.
    Zhou Y; Zhu ZL; Guan XX; Hou WW; Yu HY
    Med Hypotheses; 2009 Jul; 73(1):83-5. PubMed ID: 19278793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytes.
    Kadoshima-Yamaoka K; Murakawa M; Goto M; Tanaka Y; Inoue H; Murafuji H; Nagahira A; Hayashi Y; Nagahira K; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
    Immunol Lett; 2009 Feb; 122(2):193-7. PubMed ID: 19195485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDE8 controls CD4
    Basole CP; Nguyen RK; Lamothe K; Vang A; Clark R; Baillie GS; Epstein PM; Brocke S
    Cell Signal; 2017 Dec; 40():62-72. PubMed ID: 28851628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of breast cancer cell migration by activation of cAMP signaling.
    Dong H; Claffey KP; Brocke S; Epstein PM
    Breast Cancer Res Treat; 2015 Jul; 152(1):17-28. PubMed ID: 26022351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity.
    Wang H; Yan Z; Yang S; Cai J; Robinson H; Ke H
    Biochemistry; 2008 Dec; 47(48):12760-8. PubMed ID: 18983167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of 16,16-dimethyl PGE2 and phosphodiesterase inhibitors on Con A blastogenic responses and NK cytotoxic activity of mouse spleen cells.
    Ellis NK; Duffie GP; Young MR; Wepsic HT
    J Leukoc Biol; 1990 Apr; 47(4):371-7. PubMed ID: 2156950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1).
    Fang Y; Olah ME
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1189-200. PubMed ID: 17565009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.
    Yamamoto S; Sugahara S; Ikeda K; Shimizu Y
    Eur J Pharmacol; 2006 Nov; 550(1-3):166-72. PubMed ID: 17010967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
    McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
    Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3.
    Surapisitchat J; Jeon KI; Yan C; Beavo JA
    Circ Res; 2007 Oct; 101(8):811-8. PubMed ID: 17704206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
    Faisy C; Risse PA; Naline E; Guerot E; Fagon JY; Devillier P; Advenier C
    Life Sci; 2006 Oct; 79(20):1929-35. PubMed ID: 16820175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.
    Islam D; Zhang N; Wang P; Li H; Brubaker PL; Gaisano HY; Wang Q; Jin T
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E174-81. PubMed ID: 18854429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.